The Ambercell Solutions team participated in ECIO 2026, where the most important trends in interventional oncology emerged, from the development of ablation to multidisciplinary collaboration.
The first pulmonary cryoablation procedure was successfully performed at Tartu University Hospital. This move strengthens the development of interventional oncology services in the region and provides more minimally invasive treatment options for patients with lung tumors.
At Klaipėda University Hospital, a 70-year-old liver cancer patient who could not undergo surgery was given a minimally invasive treatment method – microwave ablation. During the procedure, the tumor is destroyed by precise exposure to heat, without damaging the surrounding tissues, and the patient’s recovery is faster and easier than after open surgery.
The session held at the University Hospital of Tartu discussed the importance of interventional oncology in the treatment of liver cancer, emphasizing the importance of multidisciplinary collaboration, innovative technologies such as AI-based planning, and economically sustainable solutions to ensure more accurate, effective and patient-tailored treatment.
The 17th CTO Days conference in Riga brought together interventional cardiology specialists from different countries for a joint analysis and exchange of experience in the treatment of complex chronic coronary artery blockages (CTOs). The program focuses on real-time procedure monitoring, clinical case analysis, and discussion of technical solutions. Such conferences directly contribute to the improvement of clinical practice and the improvement of the quality of patient care.
The first renal tumor cryoablation procedure was recently successfully performed at the Paul Stradiņš Clinical University Hospital in Latvia, a minimally invasive treatment method that allows for the precise destruction of tumor tissue, preserving healthy kidneys and ensuring faster recovery for the patient.